Treatment withα-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading

From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy

(2015) Dan Ziegler et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

(2015) Nanna B Finnerup et al.   LANCET NEUROLOGY

Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients

(2014) Dan Ziegler et al.   ACTA DIABETOLOGICA

A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy

(2014) Sherwyn Schwartz et al.   CLINICAL DRUG INVESTIGATION

Efficacy of α-lipoic acid in diabetic neuropathy

(2014) Nikolaos Papanas et al.   EXPERT OPINION ON PHARMACOTHERAPY

Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus

(2014) Jack R W Brownrigg et al.   HEART

Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations

(2014) Jennifer S. Gewandter et al.   PAIN

Challenges in design and interpretation of chronic pain trials

(2013) R.A. Moore et al.   BRITISH JOURNAL OF ANAESTHESIA

Whither pathogenetic treatments for diabetic polyneuropathy?

(2013) Andrew J. M. Boulton et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Older Subjects With Diabetes and Prediabetes Are Frequently Unaware of Having Distal Sensorimotor Polyneuropathy: The KORA F4 Study

(2012) B. W. C. Bongaerts et al.   DIABETES CARE

Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials

(2012) Gerritje S. Mijnhout et al.   International Journal of Endocrinology

Efficacy and Safety of Antioxidant Treatment With  -Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

(2011) D. Ziegler et al.   DIABETES CARE

Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy

(2011) Seward Rutkove et al.   Therapeutics and Clinical Risk Management

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

(2010) J. Calles-Escandon et al.   DIABETES CARE

Comprehensive Foot Examination and Risk Assessment: A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists

(2008) A. J.M. Boulton et al.   DIABETES CARE